MANEA

gene product
FLJ12838, mandaselin
N-glycosylation of proteins is initiated in the endoplasmic reticulum (ER) by the transfer of the preassembled oligosaccharide glucose-3-mannose-9-N-acetylglucosamine-2 from dolichyl pyrophosphate to acceptor sites on the target protein by an oligosaccharyltransferase complex. This core oligosaccharide is sequentially processed by several ER glycosidases and by an endomannosidase (E.C. 3.2.1.130), such as MANEA, in the Golgi. MANEA catalyzes the release of mono-, di-, and triglucosylmannose oligosaccharides by cleaving the alpha-1,2-mannosidic bond that links them to high-mannose glycans (Hamilton et al., 2005 [PubMed 15677381]). [supplied by OMIM, Sep 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
39 antibodies from 18 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
NovoPro Bioscience Inc.
1 antibody
Novus Biologicals
3 antibodies
Invitrogen Antibodies
3 antibodies
antibodies-online
5 antibodies
Abnova Corporation
3 antibodies
Atlas Antibodies
2 antibodies
GeneTex
2 antibodies
Proteintech Group
1 antibody
LifeSpan BioSciences, Inc.
6 antibodies
Aviva Systems Biology
1 antibody
OriGene
1 antibody
Biorbyt
2 antibodies
Boster Biological Technology
1 antibody
St John's Laboratory
1 antibody
Sigma-Aldrich
3 antibodies
Creative Diagnostics
2 antibodies
MyBioSource
1 antibody
Abgent
1 antibody